Vessela N. Kristensen

Image of Vessela N. Kristensen
Norwegian version of this page
Visiting address Kirkeveien 166 Laboratoriebygget 0450 Oslo
Postal address Postboks 4956 Nydalen OUS HF Ullevål sykehus 0424 Oslo
Tags: Molecular biology, Cancer, Life science, Biostatistics


  • Bahrami, Nazli; Jabeen, Shakila; Tahiri, Andliena; Sauer, Torill; Ødegård, Hilde Presterud & Geisler, Stephanie [Show all 11 contributors for this article] (2021). Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin. Breast Cancer Research and Treatment. ISSN 0167-6806. p. 1–15. doi: 10.1007/s10549-021-06399-x.
  • Ben-Elazar, Shay; Aure, Miriam Ragle; Jonsdottir, Kristin; Leivonen, Suvi-Katri; Kristensen, Vessela N. & Janssen, Emiel [Show all 9 contributors for this article] (2021). miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer. PLoS Computational Biology. ISSN 1553-734X. 17(2). doi: 10.1371/JOURNAL.PCBI.1008608. Full text in Research Archive
  • Aure, Miriam Ragle; Fleischer, Thomas; Bjørklund, Sunniva; Ankill, Jørgen; Castro Mondragón, Jaime Abraham & Børresen-Dale, Anne-Lise [Show all 11 contributors for this article] (2021). Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer. Genome Medicine. ISSN 1756-994X. 13. doi: 10.1186/s13073-021-00880-4. Full text in Research Archive
  • Svartdal, Lisa Gregusson; Aure, Miriam Ragle; Leivonen, Suvi-Katri; Haugen, Mads Haugland; Hongisto, Vesa & Kristensen, Vessela N. [Show all 8 contributors for this article] (2021). MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro. Scientific Reports. ISSN 2045-2322. 11. doi: 10.1038/s41598-021-90385-2. Full text in Research Archive
  • Graim, Kiley; Gorenshteyn, Dmitriy; Robinson, David G; Carriero, Nicholas J; Cahill, James A. & Chakrabarti, Rumela [Show all 14 contributors for this article] (2021). Modeling molecular development of breast cancer in canine mammary tumors. Genome Research. ISSN 1088-9051. 31(3), p. 337–347. doi: 10.1101/gr.256388.119.
  • Feng, Helian; Gusev, Alexander; Pasaniuc, Bogdan; Wu, Lang; Long, Jirong & Kristensen, Vessela N. [Show all 50 contributors for this article] (2020). Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Genetic Epidemiology. ISSN 0741-0395. 44(5), p. 442–468. doi: 10.1002/gepi.22288. Full text in Research Archive
  • Fachal, Laura; Aschard, Hugues; Beesley, Jonathan; Barnes, Daniel R.; Allen, Jamie & Kristensen, Vessela N. [Show all 50 contributors for this article] (2020). Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. ISSN 1061-4036. 52(1), p. 56–73. doi: 10.1038/s41588-019-0537-1. Full text in Research Archive
  • Escala-Garcia, Maria; Abraham, Jean; Andrulis, Irene L.; Anton-Culver, Hoda; Arndt, Volker & Børresen-Dale, Anne-Lise [Show all 51 contributors for this article] (2020). A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications. ISSN 2041-1723. 11:312, p. 1–14. doi: 10.1038/s41467-019-14100-6. Full text in Research Archive
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 82 contributors for this article] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), p. 1–14. doi: 10.1038/s41598-020-65665-y. Full text in Research Archive
  • Bergholtz, Helga; Kumar, Surendra; Wärnberg, Fredrik; Luders, Torben; Kristensen, Vessela N. & Sørlie, Therese (2020). Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer. Cancer Reports. ISSN 2573-8348. 3:e1248(3), p. 1–7. doi: 10.1002/cnr2.1248. Full text in Research Archive
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Show all 54 contributors for this article] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), p. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • Levy-Jurgenson, Alona; Tekpli, Xavier; Kristensen, Vessela N. & Yakhini, Zohar (2020). Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer. Scientific Reports. ISSN 2045-2322. 10:18802, p. 1–11. doi: 10.1038/s41598-020-75708-z. Full text in Research Archive
  • Tinholt, Mari; Stavik, Benedicte; Tekpli, Xavier; Garred, Øystein; Borgen, Elin & Kristensen, Vessela N. [Show all 9 contributors for this article] (2020). Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer. Oncoimmunology. ISSN 2162-4011. 9:e1824644(1), p. 1–12. doi: 10.1080/2162402X.2020.1824644. Full text in Research Archive
  • Tahiri, Andliena; Tekpli, Xavier; Somisetty, Venkata Satheesh; DeWijn, Rik; Luders, Torben & Bukholm, Ida Rashida Khan [Show all 9 contributors for this article] (2020). Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer. Breast Cancer Research and Treatment. ISSN 0167-6806. 183, p. 585–598. doi: 10.1007/s10549-020-05763-7. Full text in Research Archive
  • Pladsen, Arne Valebjørg; Nilsen, Gro; Rueda, Oscar M.; Aure, Miriam Ragle; Borgan, Ørnulf & Liestøl, Knut [Show all 18 contributors for this article] (2020). DNA copy number motifs are strong and independent predictors of survival in breast cancer. Communications Biology. ISSN 2399-3642. 3. doi: 10.1038/s42003-020-0884-6. Full text in Research Archive
  • Egeland, Nina Gran; Jonsdottir, Kristin; Aure, Miriam Ragle; Sahlberg, Kristine Kleivi; Kristensen, Vessela N. & Cronin-Fenton, Deirdre [Show all 10 contributors for this article] (2020). MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers. BMC Cancer. ISSN 1471-2407. 20. doi: 10.1186/s12885-020-06857-7. Full text in Research Archive
  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin & Garred, Øystein [Show all 15 contributors for this article] (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer. ISSN 0020-7136. 147(9), p. 2515–2525. doi: 10.1002/ijc.33108. Full text in Research Archive
  • Ree, Anne Hansen; Nygaard, Vigdis; Pedersen, Kjetil Boye; Heinrich, Daniel; Dueland, Svein & Bergheim, Inger Riise [Show all 25 contributors for this article] (2020). Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer?the MetAction study. Acta Oncologica. ISSN 0284-186X. p. 1–10. doi: 10.1080/0284186X.2020.1742377. Full text in Research Archive
  • Zhu, Qian; Tekpli, Xavier; Troyanskaya, Olga G. & Kristensen, Vessela N. (2020). Subtype-specific transcriptional regulators in breast tumors subjected to genetic and epigenetic alterations. Bioinformatics. ISSN 1367-4803. 36(4), p. 994–999. doi: 10.1093/bioinformatics/btz709. Full text in Research Archive
  • Shu, Xiang; Wu, Lang; Khankari, Nikhil K.; Shu, Xiao-Ou; Wang, Thomas J & Michailidou, Kyriaki [Show all 51 contributors for this article] (2019). Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. International Journal of Epidemiology. ISSN 0300-5771. 48(3), p. 795––806. doi: 10.1093/ije/dyy201.
  • Tekpli, Xavier; Lien, Tonje Gulbrandsen; Røssevold, Andreas Hagen; Nebdal, Daniel J.H.; Borgen, Elin & Ohnstad, Hege Oma [Show all 19 contributors for this article] (2019). An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature Communications. ISSN 2041-1723. 10:5499, p. 1–14. doi: 10.1038/s41467-019-13329-5. Full text in Research Archive
  • Nome, Marianne Eikhom; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone Frost & Giskeødegård, Guro F. [Show all 17 contributors for this article] (2019). Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer. ISSN 0020-7136. 146(1), p. 223–235. doi: 10.1002/ijc.32638. Full text in Research Archive
  • Parashar, Deepak; Geethadevi, Anjali; Aure, Miriam Ragle; Mishra, Jyotsna; George, Jasmine & Chen, Changliang [Show all 24 contributors for this article] (2019). miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer. Cell reports. ISSN 2211-1247. 29(13), p. 4389–4406.e10. doi: 10.1016/j.celrep.2019.11.085.
  • Levy-Jurgenson, Alona; Tekpli, Xavier; Kristensen, Vessela N. & Yakhini, Zohar (2019). Predicting Methylation from Sequence and Gene Expression Using Deep Learning with Attention. Lecture Notes in Computer Science (LNCS). ISSN 0302-9743. 11488 LNBI, p. 179–190. doi: 10.1007/978-3-030-18174-1_13.
  • Dörk, Thilo; Peterlongo, Paolo; Mannermaa, Arto; Bolla, Manjeet K.; Wang, Qin & Dennis, Joe [Show all 170 contributors for this article] (2019). Two truncating variants in FANCC and breast cancer risk. Scientific Reports. ISSN 2045-2322. 9, p. 1–14. doi: 10.1038/s41598-019-48804-y. Full text in Research Archive
  • Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N. & Nebdal, Daniel J.H. [Show all 9 contributors for this article] (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology. ISSN 1574-7891. 13(10), p. 2278–2296. doi: 10.1002/1878-0261.12561. Full text in Research Archive
  • Václavíková, Radka; Klajic, Jovana; Brynychová, Veronika; Elsnerova, Katerina; Grenaker, Grethe Irene & Tost, Jörg [Show all 12 contributors for this article] (2019). Development of high-resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma. Oncology Reports. ISSN 1021-335X. 42(2), p. 763–774. doi: 10.3892/or.2019.7186.
  • Bahrami, Nazli; Sauer, Torill; Engebretsen, Siri Strøm; Aljabri, Mohammad Belal; Bemanian, Vahid & Lindstrøm, Jonas Christoffer [Show all 17 contributors for this article] (2019). The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors. Future Oncology. ISSN 1479-6694. 15(32), p. 3675–3682. doi: 10.2217/fon-2019-0258. Full text in Research Archive
  • Escala-Garcia, Maria; Guo, Qi; Dörk, Thilo; Canisius, Sander; Keeman, Renske & Dennis, Joe [Show all 236 contributors for this article] (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer. ISSN 0007-0920. 120(6), p. 647–657. doi: 10.1038/s41416-019-0393-x. Full text in Research Archive
  • Ferreira, Manuel A.; Gamazon, Eric R.; Al-Ejeh, Fares; Aittomäki, Kristiina; Andrulis, Irene L. & Anton-Culver, Hoda [Show all 210 contributors for this article] (2019). Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications. ISSN 2041-1723. 10(1741). doi: 10.1038/s41467-018-08053-5. Full text in Research Archive
  • Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin & Funke, Simon Wolfgang [Show all 14 contributors for this article] (2019). Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research. ISSN 0008-5472. 79(16), p. 4293–4304. doi: 10.1158/0008-5472.CAN-18-1804. Full text in Research Archive
  • Johansson, Henrik J.; Socciarelli, Fabio; Vacanti, Nathaniel M.; Haugen, Mads Haugland; Zhu, Yafeng & Siavelis, Ioannis [Show all 36 contributors for this article] (2019). Breast cancer quantitative proteome and proteogenomic landscape. Nature Communications. ISSN 2041-1723. 10:1600, p. 1–14. doi: 10.1038/s41467-019-09018-y. Full text in Research Archive
  • Brinkman, Arie B.; Nik-Zainal, Serena; Simmer, Femke; Rodríguez-González, F. Germán; Smid, Marcel & Alexandrov, Ludmil B. [Show all 29 contributors for this article] (2019). Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. Nature Communications. ISSN 2041-1723. 10. doi: 10.1038/s41467-019-09828-0. Full text in Research Archive
  • Lee, Young-suk; Krishnan, Arjun; Oughtred, Rose; Rust, Jennifer; Chang, Christie S. & Ryu, Joseph [Show all 10 contributors for this article] (2019). A Computational Framework for Genome-wide Characterization of the Human Disease Landscape. Cell Systems. ISSN 2405-4712. 8(2), p. 152–162.e6. doi: 10.1016/j.cels.2018.12.010.
  • Jiang, Xia; Finucane, Hilary K.; Schumacher, Fredrick R.; Schmit, Stephanie L.; Tyrer, Jonathan P. & Han, Younghun [Show all 333 contributors for this article] (2019). Shared heritability and functional enrichment across six solid cancers. Nature Communications. ISSN 2041-1723. 10:431, p. 1–23. doi: 10.1038/s41467-018-08054-4. Full text in Research Archive
  • Nguyen, Chinh BKrong; Kumar, Surendra; Zucknick, Manuela; Kristensen, Vessela N.; Gjerstad, Johannes & Nilsen, Hilde Loge [Show all 7 contributors for this article] (2019). Associations between clinical symptoms, plasma norepinephrine and deregulated immune gene networks in subgroups of adolescent with Chronic Fatigue Syndrome. Brain, behavior, and immunity. ISSN 0889-1591. 76, p. 82–96. doi: 10.1016/j.bbi.2018.11.008. Full text in Research Archive
  • Tahiri, Andliena; Aure, Miriam Ragle & Kristensen, Vessela N. (2018). MicroRNA Networks in Breast Cancer Cells. Methods in molecular biology. ISSN 1064-3745. 1711, p. 55–81. doi: 10.1007/978-1-4939-7493-1_4.
  • Mavaddat, Nasim; Michailidou, Kyriaki; Dennis, Joe; Lush, Michael; Fachal, Laura & Lee, Andrew [Show all 56 contributors for this article] (2018). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. ISSN 0002-9297. 104(1), p. 21–34. doi: 10.1016/j.ajhg.2018.11.002.
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi & Gythfeldt, Hedda [Show all 19 contributors for this article] (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. ISSN 1756-994X. 10:92. doi: 10.1186/s13073-018-0601-y. Full text in Research Archive
  • Jabeen, Shakila; Espinoza, Jaime; Torland, Lilly Anne; Zucknick, Manuela; Kumar, Surendra & Haakensen, Vilde Drageset [Show all 15 contributors for this article] (2018). Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. :e1537691. doi: 10.1080/2162402X.2018.1537691. Full text in Research Archive
  • Tinholt, Mari; Garred, Øystein; Borgen, Elin; Beraki, Else; Schlichting, Ellen & Kristensen, Vessela N. [Show all 8 contributors for this article] (2018). Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 16(7), p. 1347–1356. doi: 10.1111/jth.14151.
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas & Kumar, Surendra [Show all 15 contributors for this article] (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. ISSN 2162-4011. 7(11), p. e1457598-1–e1457598-15. doi: 10.1080/2162402X.2018.1457598.
  • Prasmickaite, Lina; Tenstad, Ellen; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind Valen & Nord, Silje [Show all 12 contributors for this article] (2018). Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. ISSN 1574-7891. 12(9), p. 1540–1558. doi: 10.1002/1878-0261.12319. Full text in Research Archive
  • O'Mara, Tracy A.; Glubb, Dylan M.; Amant, Frédéric; Annibali, Daniela; Ashton, Katie & Attia, John [Show all 125 contributors for this article] (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. ISSN 2041-1723. 9:3166, p. 1–12. doi: 10.1038/s41467-018-05427-7. Full text in Research Archive
  • Bemanian, Vahid; Noone, John Christopher; Sauer, Torill; Touma, Joel Joul; Vetvik, Katja K & Söderberg-Naucler, Cecilia [Show all 10 contributors for this article] (2018). Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer. Breast Cancer Research and Treatment. ISSN 0167-6806. 2, p. 339–351. doi: 10.1007/s10549-018-4927-3.
  • Wu, Lang; Shi, Wei; Long, Jirong; Guo, Xingyi; Michailidou, Kyriaki & Beesley, Jonathan [Show all 210 contributors for this article] (2018). A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics. ISSN 1061-4036. 50(7), p. 968–978. doi: 10.1038/s41588-018-0132-x.
  • Mauger, Florence; Kernaleguen, Magali; Lallemand, Céline; Kristensen, Vessela N.; Deleuze, Jean-François & Tost, Jörg (2018). Enrichment of methylated molecules using enhanced-ice-co-amplification at lower denaturation temperature-PCR (E-ice-COLD-PCR) for the sensitive detection of disease-related hypermethylation. Epigenomics. ISSN 1750-1911. 10(5), p. 525–537. doi: 10.2217/epi-2017-0166.
  • Painter, Jodie N.; O'Mara, Tracy A.; Morris, Andrew P.; Cheng, Timothy H.T.; Gorman, Maggie & Martin, Lynn [Show all 76 contributors for this article] (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine. ISSN 2045-7634. 7(5), p. 1978–1987. doi: 10.1002/cam4.1445.
  • Milne, Roger L; Kuchenbaecker, Karoline B; Michailidou, Kyriaki; Beesley, Jonathan; Kar, Siddhartha & Lindström, Sara [Show all 20 contributors for this article] (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. ISSN 1061-4036. 49(12), p. 1767–1778. doi: 10.1038/ng.3785.
  • Jiao, Xiang; Aravidis, Christos; Marikkannu, Rajeshwari; Rantala, Johanna; Picelli, Simone & Adamovic, Tatjana [Show all 104 contributors for this article] (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. OncoTarget. ISSN 1949-2553. 8(61), p. 102769–102782. doi: 10.18632/oncotarget.21800. Full text in Research Archive
  • Guo, Qi; Burgess, Stephen; Turman, Constance; Bolla, Manjeet K; Wang, Qin & Lush, Michael [Show all 52 contributors for this article] (2017). Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology. ISSN 0300-5771. 46(6), p. 1814–1822. doi: 10.1093/ije/dyx131. Full text in Research Archive
  • Clancy, Trevor; dannenfelser, ruth; Troyanskaya, Olga G.; Malmberg, Karl-Johan; Hovig, Eivind & Kristensen, Vessela N. (2017). Bioinformatics approaches to profile the tumor microenvironment for immunotherapeutic discovery. Current pharmaceutical design. ISSN 1381-6128. 23(32), p. 4716–4725. doi: 10.2174/1381612823666170710154936. Full text in Research Archive
  • Helland, Thomas; Henne, Nina; Bifulco, Ersilia; Naume, Bjørn; Borgen, Elin & Kristensen, Vessela N. [Show all 15 contributors for this article] (2017). Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. Breast Cancer Research. ISSN 1465-5411. 19(1). doi: 10.1186/s13058-017-0916-4. Full text in Research Archive
  • Michailidou, Kyriaki; Lindström, Sara; Dennis, Joe; Beesley, Jonathan; Hui, Shirley & Kar, Siddhartha [Show all 359 contributors for this article] (2017). Association analysis identifies 65 new breast cancer risk loci. Nature. ISSN 0028-0836. 551(7678), p. 92–94. doi: 10.1038/nature24284.
  • Ohnstad, Hege Oma; Borgen, Elin; Falk, Ragnhild Sørum; Lien, Tonje Gulbrandsen; Aaserud, Marit & Sveli, My Anh Tu [Show all 14 contributors for this article] (2017). Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up. Breast Cancer Research. ISSN 1465-5411. 19(120). doi: 10.1186/s13058-017-0911-9. Full text in Research Archive
  • Fleischer, Thomas; Tekpli, Xavier; Mathelier, Anthony; Wang, Shixiong; Nebdal, Daniel J.H. & Dhakal, Hari Prasad [Show all 16 contributors for this article] (2017). DNA methylation at enhancers identifies distinct breast cancer lineages. Nature Communications. ISSN 2041-1723. 8(1379). doi: 10.1038/s41467-017-00510-x. Full text in Research Archive
  • Cheng, Jiqiu; Demeulemeester, Jonas; Wedge, David C.; Vollan, Hans Kristian Moen; Pitt, Jason & Russnes, Hege Elisabeth Giercksky [Show all 18 contributors for this article] (2017). Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nature Communications. ISSN 2041-1723. 8:1221, p. 1–14. doi: 10.1038/s41467-017-01355-0. Full text in Research Archive
  • Shimelis, Hermela; Mesman, Romy L.S.; Von Nicolai, Catharina; Ehlen, Asa; Guidugli, Lucia & Martin, Charlotte [Show all 133 contributors for this article] (2017). BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research. ISSN 0008-5472. 77(11), p. 2789–2799. doi: 10.1158/0008-5472.CAN-16-2568.
  • Bjørklund, Sunniva Maria Stordal; Panda, Anshuman; Kumar, Surendra; Seiler, Michael; Robinson, Doug & Gheeya, Jinesh [Show all 15 contributors for this article] (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. ISSN 2045-2322. 7(1). doi: 10.1038/s41598-017-05537-0. Full text in Research Archive
  • dannenfelser, ruth; Nome, Marianne Eikhom; Tahiri, Andliena; Ursini-Siegel, Josie; Vollan, Hans Kristian Moen & Haakensen, Vilde Drageset [Show all 12 contributors for this article] (2017). Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. OncoTarget. ISSN 1949-2553. 8(34), p. 57121–57133. doi: 10.18632/oncotarget.19078. Full text in Research Archive
  • Quigley, David; Tahiri, Andliena; Luders, Torben; Riis, Margit; Balmain, Allan & Børresen-Dale, Anne-Lise [Show all 8 contributors for this article] (2017). Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. Oncoimmunology. ISSN 2162-4011. 6(11). doi: 10.1080/2162402X.2017.1356142. Full text in Research Archive
  • Muranen, Taru A.; Greco, Dario; Blomqvist, Carl; Aittomäki, Kristiina; Khan, Sofia & Hogervorst, Frans [Show all 74 contributors for this article] (2017). Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine. ISSN 1098-3600. 19(5), p. 599–603. doi: 10.1038/gim.2016.147.
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas & Rødland, Einar Andreas [Show all 25 contributors for this article] (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research. ISSN 1078-0432. 23(16), p. 4662–4670. doi: 10.1158/1078-0432.CCR-17-0160. Full text in Research Archive
  • Aure, Miriam Ragle; Vitelli, Valeria; Jernström, Sandra Johanna; Kumar, Surendra; Krohn, Marit & Due, Eldri Undlien [Show all 34 contributors for this article] (2017). Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Research. ISSN 1465-5411. 19. doi: 10.1186/s13058-017-0812-y. Full text in Research Archive
  • Jaime A, Espinoza; Jabeen, Shakila; Batra, Richa; Papaleo, Elena; Haakensen, Vilde Drageset & Wielenga, Vera Timmermans [Show all 13 contributors for this article] (2016). Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. 5(12). doi: 10.1080/2162402X.2016.1248015.
  • Wyszynski, Asaf; Hong, Chi-Chen; Lam, Kristin; Michailidou, Kyriaki; Lytle, Christian & Yao, Song [Show all 110 contributors for this article] (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics. ISSN 0964-6906. 25(17), p. 3863–3876. doi: 10.1093/hmg/ddw223.
  • Demeulemeester, Jonas; Kumar, Parveen; Møller, Elen Kristine; Nord, Silje; Wedge, David C. & Peterson, April [Show all 20 contributors for this article] (2016). Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biology. ISSN 1465-6906. 17(1). doi: 10.1186/s13059-016-1109-7.
  • Southey, Melissa C; Goldgar, David E; Winqvist, Robert; Pylkäs, Katri; Couch, Fergus & Tischkowitz, Marc [Show all 326 contributors for this article] (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS. Journal of Medical Genetics. ISSN 0022-2593. 53(12), p. 800–811. doi: 10.1136/jmedgenet-2016-103839.
  • Hamdi, Yosr; Soucy, Penny; Adoue, Veronique; Michailidou, Kyriaki; Canisius, Sander & Lemacon, Audrey [Show all 94 contributors for this article] (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. OncoTarget. ISSN 1949-2553. 7(49), p. 80140–80163. doi: 10.18632/oncotarget.12818.
  • Pelttari, Liisa M.; Khan, Sofia; Vuorela, Mikko; Kiiski, Johanna I.; Vilske, Sara & Nevanlinna, Viivi [Show all 98 contributors for this article] (2016). RAD51B in familial breast cancer. PLOS ONE. ISSN 1932-6203. 11(5). doi: 10.1371/journal.pone.0153788.
  • Kar, Siddhartha P.; Beesley, Jonathan; Al Olama, Ali Amin; Michailidou, Kyriaki; Tyrer, Jonathan & Kote-Jarai, Zsofia [Show all 229 contributors for this article] (2016). Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discovery. ISSN 2159-8274. 6(9), p. 1052–1067. doi: 10.1158/2159-8290.CD-15-1227.
  • Fleischer, Thomas; Klajic, Jovana; Aure, Miriam Ragle; Louhimo, Riku; Pladsen, Arne Valebjørg & Ottestad, Lars [Show all 18 contributors for this article] (2016). DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. OncoTarget. ISSN 1949-2553. 8(1), p. 1074–1082. doi: 10.18632/oncotarget.13718.
  • Liu, Jingjing; Lončar, Ivona; Collée, J. Margriet; Bolla, Manjeet K.; Dennis, Joe & Michailidou, Kyriaki [Show all 99 contributors for this article] (2016). Rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports. ISSN 2045-2322. 6. doi: 10.1038/srep36874.
  • Painter, Jodie N.; O'Mara, Tracy A.; Marquart, Louise; Webb, Penelope M.; Attia, John & Medland, Sarah E. [Show all 72 contributors for this article] (2016). Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 25(11), p. 1503–1510. doi: 10.1158/1055-9965.EPI-16-0147.
  • Kaveh, Fatemeh; Baumbusch, Lars Oliver; Nebdal, Daniel J.H.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian & Edvardsen, Hege [Show all 8 contributors for this article] (2016). A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer. ISSN 1471-2407. 16(913). doi: 10.1186/s12885-016-2899-4.
  • Horne, Hisani N.; Chung, Charles C.; Zhang, Han; Yu, Kai; Prokunina-Olsson, Ludmila & Michailidou, Kyriaki [Show all 114 contributors for this article] (2016). Fine-mapping of the 1p11.2 breast cancer susceptibility locus. PLOS ONE. ISSN 1932-6203. 11:e0160316(8). doi: 10.1371/journal.pone.0160316.
  • Ghoussaini, Maya; French, Juliet D.; Michailidou, Kyriaki; Nord, Silje; Beesley, Jonathan & Canisus, Sander [Show all 123 contributors for this article] (2016). Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen-receptor-positive breast cancer through FGF10 and MRPS30 regulation. American Journal of Human Genetics. ISSN 0002-9297. 99(4), p. 903–911. doi: 10.1016/j.ajhg.2016.07.017.
  • Thienpont, Bernard; Steinbacher, Jessica; Zhao, Hui; D'Anna, Flora; Kuchnio, Anna & Ploumakis, Athanasios [Show all 19 contributors for this article] (2016). Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. ISSN 0028-0836. 537(7618), p. 63–68. doi: 10.1038/nature19081.
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua & Körner, Cindy [Show all 38 contributors for this article] (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine. ISSN 1757-4676. 8(9), p. 1052–1064. doi: 10.15252/emmm.201606198. Full text in Research Archive
  • Guo, Yan; Warren Andersen, Shaneda; Shu, Xiao-Ou; Michailidou, Kyriaki; Bolla, Manjeet K. & Wang, Qin [Show all 110 contributors for this article] (2016). Genetically predicted body mass index and breast cancer risk: mendelian randomization analyses of data from 145,000 women of European descent. Nature Methods. ISSN 1548-7091. 13:e1002105(8). doi: 10.1371/journal.pmed.1002105.
  • Darabi, Hatef; Beesley, Jonathan; Droit, Arnaud; Kar, Siddhartha; Nord, Silje & Marjaneh, Mahdi Moradi [Show all 112 contributors for this article] (2016). Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific Reports. ISSN 2045-2322. 6. doi: 10.1038/srep32512.
  • Dominguez Valentin, Mev; Gras Navarro, Andrea; Rahman, Mohummad Aminur; Kumar, Surendra; Retière, Christèle & Ulvestad, Elling [Show all 14 contributors for this article] (2016). Identification of a natural killer cell receptor allele that prolongs survival of cytomegalovirus-positive glioblastoma patients. Cancer Research. ISSN 0008-5472. 76(18), p. 5326–5336. doi: 10.1158/0008-5472.CAN-16-1162.
  • Lawrenson, Kate; Kar, Siddhartha; McCue, Karen; Kuchenbaeker, Karoline; Michailidou, Kyriaki & Tyrer, Jonathan [Show all 281 contributors for this article] (2016). Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. ISSN 2041-1723. 7:12675. doi: 10.1038/ncomms12675.
  • Tinholt, Mari; Sandset, Per Morten; Mowinckel, Marie-Christine; Garred, Øystein; Sahlberg, Kristine Kleivi & Kristensen, Vessela N. [Show all 10 contributors for this article] (2016). Determinants of acquired activated protein C resistance and D-dimer in breast cancer. Thrombosis Research. ISSN 0049-3848. 145, p. 78–83. doi: 10.1016/j.thromres.2016.08.003.
  • Schmidt, Marjanka K.; Hogervorst, Frans; Van Hien, Richard; Cornelissen, Sten; Broeks, Annegien & Adank, Muriel A. [Show all 84 contributors for this article] (2016). Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers. Journal of Clinical Oncology. ISSN 0732-183X. 34(23), p. 2750–2760. doi: 10.1200/JCO.2016.66.5844.
  • Shi, Jiajun; Zhang, Yanfeng; Zheng, Wei; Michailidou, Kyriaki; Ghoussaini, Maya & Bolla, Manjeet K. [Show all 128 contributors for this article] (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer. ISSN 0020-7136. 139(6), p. 1303–1317. doi: 10.1002/ijc.30150.
  • Lesurf, Robert; Aure, Miriam Ragle; Mørk, Hanne Håberg; Vitelli, Valeria; Lundgren, Steinar & Børresen-Dale, Anne-Lise [Show all 10 contributors for this article] (2016). Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. Cell reports. ISSN 2211-1247. 16(4), p. 1166–1179. doi: 10.1016/j.celrep.2016.06.051. Full text in Research Archive
  • Couch, Fergus J.; Kuchenbaecker, Karoline B.; Michailidou, Kyriaki; Mendoza-Fandino, Gustavo A.; Nord, Silje & Lilyquist, Janna [Show all 249 contributors for this article] (2016). Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. ISSN 2041-1723. 7:11375. doi: 10.1038/ncomms11375. Full text in Research Archive

View all works in Cristin

View all works in Cristin

Published Apr. 13, 2011 2:55 PM - Last modified Oct. 1, 2019 11:12 AM